Renal failure vaccine - ProthericsAlternative Names: Kidney failure vaccine - Protherics; Nephropathy immunotherapeutic - Protherics; Renal vaccine - Protherics
Latest Information Update: 23 Nov 2009
At a glance
- Originator Protherics
- Developer BTG
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Renal failure
Most Recent Events
- 04 Dec 2008 Protherics has been acquired and merged into BTG
- 02 Oct 2001 Preclinical development for Renal failure in United Kingdom (Unknown route)